Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Go back to Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 9.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.06 | 52 Week High | $5.40 | |||
| Open | $9.06 | 52 Week Low | $1.88 | |||
| Day High | $9.06 | P/E | N/A | |||
| Day Low | $9.06 | EPS | $0.00 | |||
| Volume | 18,735 | |||||
